I agree that this site is using cookies. You can find further informations here.
X
Brill, Margreke JE
29  results:
Search for persons X
?
1

Model-Informed Translation of In Vitro Effects of Short-, P..:

Minichmayr, Iris ; Kappetein, Suzanne ; Brill, Margreke.
Antibiotics.  11 (2022)  8 - p. 1036 , 2022
Link: https://doi.org/10.3390/..
 
?
2

The Pharmacokinetics of the CYP3A Substrate Midazolam in Mo..:

Brill, Margreke J. ; van Rongen, Anne ; van Dongen, Eric P....
Pharmaceutical Research.  32 (2015)  12 - p. 3927-3936 , 2015
Link: https://doi.org/10.1007/..
 
?
3

Population pharmacokinetic-pharmacodynamic model of propofo..:

Blussé van Oud-Alblas, Heleen J. ; Brill, Margreke J. E. ; Peeters, Mariska Y. M....
BMC Anesthesiology.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
4

Characterization of Intestinal and Hepatic CYP3A-Mediated M..:

Brussee, Janneke M. ; Yu, Huixin ; Krekels, Elke H. J....
Pharmaceutical Research.  35 (2018)  9 - p. , 2018
Link: https://doi.org/10.1007/..
 
?
5

First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gu..:

Brussee, Janneke M. ; Yu, Huixin ; Krekels, Elke H. J....
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  6 - p. 374-383 , 2018
Link: https://doi.org/10.1002/..
 
?
6

Higher Midazolam Clearance in Obese Adolescents Compared wi..:

van Rongen, Anne ; Brill, Margreke J. E. ; Vaughns, Janelle D....
Clinical Pharmacokinetics.  57 (2017)  5 - p. 601-611 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Confirming model-predicted pharmacokinetic interactions bet..:

Brill, Margreke J.E. ; Svensson, Elin M. ; Pandie, Mishal..
International Journal of Antimicrobial Agents.  49 (2017)  2 - p. 212-217 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Drug Disposition in Obesity: Toward Evidence-Based Dosing:

Knibbe, Catherijne A.J. ; Brill, Margreke J.E. ; van Rongen, Anne...
Annual Review of Pharmacology and Toxicology.  55 (2015)  1 - p. 149-167 , 2015
Link: https://doi.org/10.1146/..
 
?
9

Midazolam Pharmacokinetics in Morbidly Obese Patients Follo..:

Brill, Margreke J. E. ; van Rongen, Anne ; Houwink, Aletta P. I....
Clinical Pharmacokinetics.  53 (2014)  10 - p. 931-941 , 2014
Link: https://doi.org/10.1007/..
 
?
10

Impact of Obesity on Drug Metabolism and Elimination in Adu..:

Brill, Margreke J.E. ; Diepstraten, Jeroen ; van Rongen, Anne...
Clinical Pharmacokinetics.  51 (2012)  5 - p. 277-304 , 2012
Link: https://doi.org/10.2165/..
 
?
11

Population pharmacokinetics of colistin and the relation to..:

Kristoffersson, Anders N ; Rognås, Viktor ; Brill, Margreke JE...
Clinical Microbiology and Infection, 1198-743X, 2020, 26:12, s. 1644-1650.  , 2020
Link: http://urn.kb.se/resolve..
 
?
12

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gu..:

Brussee, Janneke M ; Yu, Huixin ; Krekels, Elke H. J...
CPT : Pharmacometrics and Systems Pharmacology (PSP), 2018, 7:6, s. 374-383.  , 2018
Link: http://urn.kb.se/resolve..
 
?
13

Confirming model-predicted pharmacokinetic interactions bet..:

Brill, Margreke JE ; Svensson, Elin M ; Pandie, Mishal..
International Journal of Antimicrobial Agents, 0924-8579, 2017, 49, s. 212-217.  , 2017
Link: http://urn.kb.se/resolve..
 
?
14

Model-Informed Translation of In Vitro Effects of Short-, P..:

Minichmayr, Iris ; Kappetein, Suzanne ; Brill, Margreke J. E.
Antibiotics, 0066-4774, 2022, 11:8,.  , 2022
Link: http://urn.kb.se/resolve..
 
?
15

Model-Informed Translation of In Vitro Effects of Short-, P..:

Minichmayr, Iris K ; Kappetein, Suzanne ; Brill, Margreke J. E.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404958/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15